For more information about Dana-Farber's Breast Oncology Center, visit

ESMO Breast Cancer 2026 Highlights: Pumitamig + DB-1305/BNT325 | Dana-Farber Cancer Institute

172 views · 2026-05-28 13:38:17

ESMO Breast Cancer 2026 Highlights: Saci-IO HR+ | Dana-Farber Cancer Institute

152 views · 2026-05-28 13:36:59

ESMO Breast Cancer 2026 Highlights: SERENA-6 | Dana-Farber Cancer Institute

163 views · 2026-05-28 13:34:32

ESMO Breast Cancer 2026 Highlights: TRAK-ER | Dana-Farber Cancer Institute

162 views · 2026-05-28 13:32:34

ESMO Breast Cancer 2026 Highlights Panel Discussion | Dana-Farber Cancer Institute

748 views · 2026-05-27 20:32:31

2025 SABCS Highlights: Patient Perspective | Dana-Farber Cancer Institute

767 views · 2026-03-09 14:20:23

Vaginal Estrogen Use in Patients with a History of Breast Cancer | Dana-Farber Cancer Institute

1K views · 2026-03-03 19:20:23

2025 SABCS Highlights: First-Line Tx for HER2+ Advanced Breast Cancer | Dana-Farber Cancer Institute

430 views · 2026-03-02 19:22:26

2025 SABCS Highlights: Hormone Replacement Therapy for Breast Cancer | Dana-Farber Cancer Institute

495 views · 2026-02-27 18:50:22

2025 SABCS Highlights: Advances in Oral SERDs for Breast Cancer | Dana-Farber Cancer Institute

404 views · 2026-02-27 18:47:24

2025 SABCS Highlights: Advances in ADCs for Advanced Breast Cancer | Dana-Farber Cancer Institute

319 views · 2026-02-26 15:40:08

2025 SABCS Highlights: Advances in ctDNA for Breast Cancer | Dana-Farber Cancer Institute

452 views · 2026-02-26 15:40:03

2025 SABCS Highlights: Targeted Therapies for Advanced Breast Cancer | Dana-Farber Cancer Institute

543 views · 2026-02-25 21:23:44

SABCS 2025 Breast Cancer Highlights Panel Discussion | Dana-Farber Cancer Institute

2K views · 2026-01-29 19:46:20